贫血对老年急性冠状动脉综合征患者经皮冠状动脉介入治疗术后预后的影响被引量：6

Impact of Anemia on Prognosis of Elder Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention

在线阅读下载PDF

导出

摘要目的:评价贫血对老年急性冠状动脉综合征(ACS)患者经皮冠状动脉介入治疗(PCI)术后预后的影响。方法:入选2010-06至2012-06接受单纯PCI术的老年(年龄>60岁)ACS患者908例,根据世界卫生组织对贫血的定义(血红蛋白女性<12.0 g/dl、男性<13.0 g/dl)将患者分为贫血组(283例)和非贫血组(625例),比较两组患者的临床特征。PCI术后对患者进行1年的随访,比较两组患者的病死率和主要心脑血管不良事件(MACCE:包括心原性死亡、心肌再梗死、心功能恶化、靶血管再次血运重建、脑出血、脑梗死)的发生率。结果:31%的老年ACS患者患有贫血。贫血组的ACS患者高龄、女性、糖尿病、高血压、慢性肾功能不全、射血分数降低以及三支血管病变的比例明显高于非贫血组(P<0.05)。PCI术后1年的病死率和MACCE发生率明显高于非贫血组(P<0.05)。多因素回归分析显示,贫血是老年ACS患者PCI术后1年病死率的一个独立预测因素(P<0.05)。结论 :贫血可增加老年ACS患者PCI术后长期的总死亡率和MACCE。 Objective： To evaluate the impact of anemia on prognosis of elder patients with acute coronary syndrome（ACS） after percutaneous coronary intervention（PCI）.Methods： A total of 908 consecutive ACS patients elder than 60 years of age with PCI in our hospital from 2010-06 to 2012-06 were studied. According to WHO definition of anemia（HB12.0 g/d L in female and HB13.0 g/d L in male）, the patients were classified as Anemia group, n=283 and Non-anemia group, n=625. The patients were followed-up for 1 year. The basic clinical characteristics, incidences of mortality and major adverse cardiovascular and cerebravascular events（MACCE） were compared between 2 groups by cardiac death, myocardial re-infarction, worsening of cardiac function, target vessel revascularization, cerebral hemorrhage and cerebral infarction.Results： There were 31% of patients suffering from anemia. Anemia group had more patients with the elder age, female gender, diabetes, hypertension, chronic kidney disease, decreased LVEF, more patients with 3 vessel-disease, and higher mortality at 1 year after PCI, higher rate of MACCE than those in Non-anemia group, all P0.05. Multiple regression analysis indicated that anemia is the independent predictor for mortality in elder ACS patients at 1 year after PCI, P0.05.Conclusion： Anemia may increase the incidences of mortality and MACCE in elder ACS patients after PCI for a long-term.

作者闫振娴周玉杰赵迎新周志明郭永和贾德安韩红亚马茜

机构地区首都医科大学附属北京安贞医院心内

出处《中国循环杂志》 CSCD 北大核心 2014年第12期968-971,共4页 Chinese Circulation Journal

关键词贫血老年急性冠状动脉综合征经皮冠状动脉介入治疗预后 Anemia Elderly Acute coronary syndrome Percutaneous coronary intervention Prognosis

分类号 R54 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献22

1Valeur N, Nielsen OW, MeMurray JJ, et al. Anaemia is an independent predictor of mortality in patients with left ventricular systolic dysfunction following acute myocardial infarction. Eur J Heart Fail, 2006, 8: 577-584.
2MeKechnie RS, Smith D, Montoye C, et al. Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation, 2004, 110:271-277.
3Archlmid RA, Balami D, A1-Hajiri A, et al. Hemoglobin concentration is an independent determinant of heart failure in acute coronary syndromes: cohort analysis of 2310 patients. Am Heart J, 2006, 152: 1091-1095.
4DeFoe GR, Ross CS, Olmstead EM, et al. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Ann Thorac Surg, 2001, 71: 769-776.
5Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes. Circulation, 2003, 107: 223-225.
6Kurek TI, Lenarczyk R, Kowalczyk J, et al. Effect of anemia in high- risk groups of patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol, 2010, 105: 611- 618.
7World Health Organization. Nutritional anaemias: report of a WHO scientific group. World Health Organ Tech Rep Ser, 1968, 405: 33- 37.
8Wu WC, Rathnre SS, Wang Y, et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med, 2001, 345: 1230-1236.
9Felt FI, Voehz MD, Attubato MJ, et al. Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial. Am J Cardiol, 200?, 100 : 1364-1369.
10Nikolsky EI, Aymong ED, Halkin A, et al. hnpact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coil Cardiol, 2004, 44: 547- 553.

二级参考文献46

1马迎春,左力,王梅,周玉红,张春丽,徐国宾,王海燕.肾小球滤过率评估方程在慢性肾脏病不同分期中的适用性[J].中华内科杂志,2005,44(4):285-289. 被引量：82
2宋现涛,吕树铮,陈韵岱,苑飞,林运,田锐,陈欣,金泽宁,周渊,葛长江,孟康,柳弘.经皮冠状动脉介入治疗后患者住院期间合并上消化道出血分析[J].中华心血管病杂志,2007,35(4):308-311. 被引量：36
3Miranda E, Pena MA, Castellanos J, et al. Predictors of mortality and adverse outcome in elderly high-rlsk patients undergoing percutaneous coronary intervention. Arch Cardiol Mex ,2007,77 : 194-199.
4Rizo-Patron C, Hamad N, Paulus R, et al. Percutaneous transluminal coronary angioplasty in octogenarians with unstable coronary syndromes. Am J Cardiol, 1990,66 : 857-858.
5Kern M J, Deligonul U, Galan K, et al. Percutaneous transluminal coronary angioplasty in octogenarians. Am J Cardiol, 1988,61:457-458.
6Batchelor WB, Anstrom K J, Muhlbaier LH, et al. Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions:results in 7,472 octogenarians. National Cardiovascular Network Collaboration. J Am Coil Cardiol,2000 ,36 :723-730.
7Costa JR, Sousa A, Moreira AC, et al. Drug-eluting stents in the elderly:long-term ( > one year) clinical outcomes of octogenarians in the DESIRE ( Drug-Eluting Stents In the REal world) registry. J Invasive Cardio1,2008 ,20 :404-410.
8Zimmermann S, Ruthrof S, Nowak K, et al. Outcomes of contemporary interventional therapy of ST elevation infarction in patients older than 75 years. Clin Cardiol,2009 ,32 :87-93.
9Teplitsky I, Assali A, Lev E, et al. Results of pereutaneous coronary interventions in patients > or = 90 years of age. Catheter Cardiovasc Interv, 2007,70 : 937 -943.
10Boudou N, Roncalli J, Lhermusier T, et al. Long-term clinical outcome after percutaneous coronary interventions in the elderly:results for 512 consecutive patients. EuroIntervention,2008,3 : 512 -517.